Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543500 | NSE Symbol : | ISIN : INE0JVD01011 | Industry : Trading |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
10-Apr-2025	25-Apr-2025	EGM	Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/04/2025 inter alia to consider and approve Calling of Board Meeting on Friday 18th April 2025 at 03:00 P.M. Pursuant to regulation 30 and regulation 29 of the SEBI (Listing Obligations & Disclosure Requirement) 2015, we hereby inform you that Board of Directors in their meeting held on today, i.e. Friday, 18th April, 2025 at the Registered Office of the Company, situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060 which commenced at 3:00 P.M and concluded at 04:15 P.M. has decided to postponed and rescheduled the Board Meeting on Friday, 25th April, 2025 at 03:00 P.M., at the registered office of the Company to discuss and consider agenda mentioned in the attached file. Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 ,inter alia, to consider and approve Pursuant to regulation 30 and regulation 29 of the SEBI (Listing Obligations & Disclosure Requirement) 2015, we hereby inform you that Board of Directors in their meeting held on today, i.e. Friday, 18th April, 2025 at the Registered Office of the Company, situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060 which commenced at 3:00 P.M and concluded at 04:15 P.M. has decided to postponed and rescheduled the Board Meeting on Friday, 25th April, 2025 at 03:00 P.M., at the registered office of the Company to discuss and consider agenda as mentioned in the attached intimation (As per BSE Announcement Dated on 18/04/2025)
03-Apr-2025	10-Apr-2025	Accounts	Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/04/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday 10th April 2025 at 03:00 P.M. at the registered office of the Company i.e. A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380 060 inter alia to consider and approve: 1. The Audited Financial Results of the Company for the Half Year and Year ended on 31st March 2025 along with Auditors Report. 2. Proposal of raising of funds by way of issue of Equity shares and/or Warrants on Preferential basis. 3. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting. Kindly find attached outcome (As Per Bse Announcement Dated on 10.04.2025)
03-Mar-2025	03-Mar-2025	Quarterly Results	Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. On 3rd March, 2025 at the Registered Office of the Company, situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060 which commenced at 4:00 P.M and concluded at 5:00 P.M. has considered and approved Unaudited Financial Results for the Half Year ended on 30th September, 2024 along with Limited Review Report.
21-Jan-2025	21-Jan-2025	Change in Auditors	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. Tuesday, 21st January, 2025 at the Registered Office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola, Ahmedabad - 380 060 which commenced at 05:00 P.M. and concluded at 07:15 P.M. has considered and approved Appointment of M/s. H Thakkar & Co. LLP, (FRN: W100891), Mumbai, as the Statutory Auditor of the Company on the recommendation of Audit Committee for the Financial Year 2024-25, subject to approval of the members in the General Meeting within three months from the date of appointment by the Board of Directors.
01-Oct-2024	01-Oct-2024	Change in Directors	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e., Tuesday, 1st October 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380 060 which commenced at 5:00 P.M. and concluded at 6:00 P.M., inter-alia has considered and approved: 1. Appointment of Ms. Aesha Harsh Shah (DIN: 10423365) as Additional Non-Executive Independent Director of the Company w.e.f 1st October, 2024. 2. Resignation of Mr. Pranav Manoj Vajani (DIN: 09213749) from Independent Director of the Company w.e.f 1st October, 2024. 3. Reconstitution of the Audit Committee of the Company w.e.f. 1st October, 2024 4. Reconstitution of the Nomination and Remuneration Committee of the Company w.e.f. 1st October, 2024
06-Sep-2024	06-Sep-2024	Change in Directors	Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. on 6th September, 2024 at A-1106, Empire Business Hub, Nr. AUDA Water Tank, Science City Road, Sola, Ahmedabad, Gujarat, 380060 which commenced at 05:30 P.M. and concluded at 08:30 P.M., has inter alia considered and approved as per attachment
01-Aug-2024	01-Aug-2024	Change in Directors	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e., Thursday, 1st August 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380 060 which commenced at 6:00 P.M. and concluded at 6:30 P.M., inter-alia has considered and approved 1. Appointment of Mr. Bhumishth Narendrabhai Patel (DIN: 02516641) as Managing Director of the Company w.e.f 1st August, 2024. 2. Resignation of Ms. Payal Bhumishth Patel (DIN: 05300011) from Managing Director of the Company w.e.f 1st August, 2024
22-Jun-2024	22-Jun-2024	Preferential Issue	Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 22nd June, 2024 at the Registered Office of the Company which commenced at 02:00 P.M. and concluded at 02:30 P.M. has considered and approved Allotted 1,13,00,000 (One Crore and Thirteen Lakhs Thousand) fully paid-up Equity shares of face value of Rs. 10.00/- (Rupees Ten Only) per share, at a price of Rs. 17/- (Rupees Seventeen Only) per share, aggregating to Rs. 19,21,00,000/- (Rupees Nineteen Crore Twenty One Lakhs Only) for cash consideration to the person(s)/ entity(ies) belonging to Non-Promoter category on a preferential basis in accordance with provisions of Chapter V of SEBI (ICDR) Regulations, 2018, as mentioned in 'Annexure - I'.
20-May-2024	27-May-2024	Accounts	Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a Meeting of the Board of Directors of the Company will be held on Monday 27th May 2024 at 4:00 P.M. at A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380060 to consider and approve the Audited Financial Results of the Company for the Half-year and year ended on 31st March 2024 along with Auditors Report. Pursuant to Regulations 30 (6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., on 27th May, 2024, at the registered Office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380060, which commenced at 04:00 P.M. and concluded at 8:00 P.M., inter alia has considered and approved Audited Financial Results of the Company for the Half Year and Year ended on 31st March, 2024 along with Auditors report. Read less.. (As Per BSE Announcement Dated on 27.05.2024)
03-Feb-2024	03-Feb-2024	Change in Directors	Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 3rd February, 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India, 380 060 which commenced at 3:00 P.M. and concluded at 4:00 P.M. inter-alia has, considered and approved: 1. Appointment of Ms. Gitika Mishra as Company Secretary and Compliance officer of the Company w.e.f. 3rd February, 2024. 2. Appointment of Ms. Payal Patel (DIN: 05300011) as Managing Director of the Company w.e.f 3rd February, 2024. 3. Resignation of Mr. Bhumishth Patel (DIN:02516641) from Managing Director of the Company w.e.f. 3rd February, 2024. 4. Decided to hold Extra Ordinary General Meeting of the Company on Wednesday, 28th February, 2024 at 4:00 PM. Intimation under Regulation 30 (LODR), 2015 for appointment of Company Secretary and Compliance officer Announcement under Regulation 30 (LODR), 2015, Appointment of Managing Director Announcement under Regulation 30 (LODR) 2015, Resignation of Managing Director Intimation and Outcome under regulation 30 (LODR), 2015
16-Jan-2024	22-Jan-2024	Raising funds through Debt Instr.	Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 inter alia to consider and approve and discuss proposal of raising of funds by way of issue of Equity shares on preferential allotment basis for cash consideration subject to the receipt of necessary approvals. Further pursuant to Clause 4 of Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and Companys Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities we hereby inform you that the trading window for dealing in Equity Shares of the Company by the Insiders will be closed from Tuesday 16th January 2024 till 48 hours after the conclusion of the meeting. Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 22nd January, 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India, 380 060 which commenced at 2:00 P.M. and concluded at 3:00 P.M. interalia has, considered and approved as per attachment. (As Per BSE Announcement Dated on 22/01/2024)
31-Oct-2023	10-Nov-2023	Quarterly Results	Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 8th November 2023 at 5:00 P.M. at A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380 060 inter alia to consider and approve the Unaudited Financial Results of the Company for the Quarter and half year ended on 30th September 2023 along with Limited Review Report. Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company held today i.e. Wednesday, 8th November, 2023 at 5:00 P.M. at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060 it has been stands postponed to 10th November, 2023 at the same time and venue inter-alia to discuss, consider and approve inter alia, to consider and approve the Unaudited Financial Results of the Company for the Quarter and half year ended on 30th September, 2023 along with Limited Review Report. (As per BSE Announcement Dated on 08/11/2023) Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. On 10th November, 2023 at the Registered Office of the Company, situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060 which commenced at 5:00 P.M and concluded at 6:00 P.M. has considered and approved Unaudited Financial Results for the Half Year ended on 30th September, 2023 along with Limited Review Report. Submission of Unaudited Financial Results for the Half Year ended on 30th September,2023 along with Limited review Report. (As Per BSE Announcement dated on 10.11.2023)
11-Sep-2023	11-Sep-2023	Change in Directors	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 11th September, 2023 at the Registered Office of the Company which commenced at 5:00 P.M. and concluded at 5:30 P.M. inter-alia has considered and approve the business mentioned in the Outcome.
10-May-2023	25-May-2023	Accounts	Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2023 inter alia to consider and approve We hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday 25th May 2023 at 3:00 P.M. at the Registered Office of the Company situated at A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad 380060 inter alia to consider and approve the Audited Financial Results of the Company for the Half Year and Year ended on 31st March 2023 along with Auditors Report. Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 read with SEBI (Prohibition of Insider Trading) (Amendment) Regulations 2018 read with Circular No. LIST/COMP/01/2019-20 dated 2nd April 2019 issued by BSE the Trading Window has been closed with effect from 1st April 2023 and shall continue to remain closed till 48 hours after the announcement of the financial results on 25th May 2023. Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. 25th May, 2023, at the Registered Office of the Company which commenced at 3:00 P.M. and concluded at 6:35 P.M. inter-alia has considered and approved: 1. Audited Financial Results for the Half Year and Financial Year ended on 31st March, 2023 along with Auditor's Report and Declaration. 2. Appointment of Mr. Dahyabhai Patel (DIN: 07061899) as a Managing Director of the Company w.e.f. 25th May, 2023, subject to approval of the Shareholders in the General Meeting. 3. Resignation of Mr. Tarunkumar Patel (DIN: 09433349) as a Director of the Company w.e.f. 25th May, 2023. (As Per BSE Announcement Dated on 25.05.2023)
15-Oct-2022	07-Nov-2022	Half Yearly Results	Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on 7th November 2022 at 3:00 P.M. at the registered office of the Company situated at A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380 060 inter alia to consider and approve the Unaudited Financial Results of the Company for the Half Year ended on 30th September 2022 along with Limited Review Report. Please take note of the same and oblige. Half Yearly Results & Right Issue of Equity Shares (As Per BSE Bulletin Dated on 01.11.2022) Board approved:- 1. Issue of 4,89,60,000 Equity Shares of face value of Rs. 10/- at par aggregating of Rs. 48,96,00,000/- to all existing members of the Company on rights ('Rights Issue'). a) 18 equity shares for every 5 equity share held by the eligible equity shareholders in the Company as on record date with right announce. b) Amount for Rights Equity Shares shall be payable by the eligible shareholders in the following manner: 1. Rs. 2.50/- at the time of allotment 2. Rs. 2.50/- at the time of First Call 3. Rs. 2.50/- at the time of Second Call 4. Rs. 2.50/- at the time of Third and Final Call (As Per BSE Bulletin Dated on 07.11..2022) Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. on 7th November, 2022 at the Registered Office of the Company, which commenced at 3:00 P.M. and concluded at 5:30 P.M. inter-alia, has to considered and approved as per attachment. (As Per BSE Announcement Dated on 07.11.2022)

1 2

LOGIN HERE

Evoq Remedies Ltd

Board Meeting